China's 'National Team' Pours ¥170B into Market This Month; Analysts Warn It Can't Sustain a Lasting Rally
nashnova research
State-backed entities led by Central Huijin injected roughly ¥170 billion (US$25.5 billion) into A-shares this month, yet the CSI 300 has still fallen more than 20% from its June peak into a technical bear market; Macquarie, Julius Baer, and Goldman Sachs warn that floor-setting purchases cannot drive a lasting rebound — only a genuine domestic-demand recovery can.
¥170 billion deployed — what did it actually buy, and how much did it help?
State-owned entities led by Central Huijin（中央汇金）bought ETFs and other instruments this month, injecting roughly ¥170 billion (≈US$25.5 billion) into the market.
The CSI 300 rose 0.9% on Wednesday. But year-to-date it is still down 10%, and more than 20% off its June high — crossing into a technical bear market (a decline of 20%+ from a recent peak).
This means → the state's money is enough to "hold the floor," but not enough to "lift the building." Analysts are explicit: the buying aims to prevent systemic risk, not to push prices sustainably higher.
The money went in — why can't the market rally?
Macquarie wrote in a research note: "A sustained rally depends on a domestic-demand recovery — which may not come until Beijing can no longer rely on exports to drive growth."
Goldman Sachs' chief China equity strategist Kinger Lau flagged fiscal-policy contraction as the biggest "surprise" since the start of the year, noting that "fiscal policy has shifted from expansion to contraction."
In plain terms = the market was counting on the government to spend big to stimulate the economy; instead, the government tightened its purse strings — and each time expectations were disappointed, stocks fell further.
How bad are the economic numbers?
Fixed-asset investment fell 7.2% year-on-year through the first three quarters. Retail sales declined in May for the first time since late 2022 and have stayed weak since.
A new round of mortgage subsidies announced last month was widely seen as too modest to meaningfully revive a property sector mired in a nearly five-year slump.
This means → investment, consumption, and property — all three pillars — are weakening simultaneously. Buying stocks with state funds cannot fix the economy itself.
Why is Hong Kong selling off too?
Mainland investors net-sold roughly HK$20 billion (≈US$2.5 billion) in Hong Kong stocks this month, according to the Financial Times. October is on track to be the largest single month of mainland outflows from Hong Kong since July 2021.
Aberdeen Investments' Asia equities head, Kenneth Akintewe, pointed to Beijing's tightened scrutiny of offshore wealth and trusts as a trigger for selling by high-net-worth investors.
Kinger Lau added that the tax-policy shift "from a broader perspective, is simply another expression of fiscal tightening." This reflects that Hong Kong's pressure is not just sentiment contagion — it is an extension of the same policy-contraction logic.
Which sectors have been hit hardest?
AI hardware and industrial stocks led the decline. The CSI 300 industrials sub-index is down 23% year-to-date.
CATL's Shenzhen-listed shares have fallen 37% this year; CXMT（长鑫存储）, which listed to fanfare in July, has dropped 20% in the past month alone.
In plain terms = the "China manufacturing upgrade" story the market was most bullish on has, under the twin pressures of weak domestic demand and capital outflows, fallen the hardest.
What matters next?
Whether state funds can prevent further declines hinges on a single variable: whether domestic demand stages a meaningful recovery.
Macquarie and Julius Baer both argue the market may stabilize temporarily thanks to state buying, but any sustainable gain ultimately requires improved corporate earnings and a consumer-spending rebound.
This means → if retail and investment data show no clear improvement over the next quarter or two, the cushion from this ¥170 billion will gradually fade — the market needs an economic turning point, not more floor-setting capital.
市场有风险，内容仅供研究参考，不构成投资建议。